Singapore, May 13 -- Polycystic Ovary Syndrome (PCOS) has been renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS), following a 14-year global effort, led by Monash University in Australia, to improve diagnosis and care.

The condition, affecting more than 170 million women worldwide, or more than one in eight, was misunderstood to be "all about ovarian cysts".

PMOS is characterised by fluctuations in hormones, with impacts on weight, metabolic and mental health, skin, and the reproductive system.

Professor Helena Teede, Director, Monash Centre for Health Research & Implementation and endocrinologist, Monash Health, Melbourne, Australia, led the name change process after decades of research into the condition and seeing patient impa...